CLINICAL_TRIALS
trial_result
· 2012-06-04
Clinical Trial Update: Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults [Phase 1]
Summary
A Phase 1 trial comparing monotherapy to placebo in healthy adults and adults with chronic hepatitis C was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic, Hepatitis C | Phase 1 | Status: TERMINATED